Vigeo Therapeutics, Inc.

10:00 AM - 10:15 AM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
Vigeo Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics that can effectively treat multiple types of cancer and improve the lives of patients.
Company Type:
Company Website:
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
VT1021
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided